PLEVKA, Pavel, Rushika PERERA, Moh Lan YAP, Jane CARDOSA, Richard KUHN a Michael G. ROSSMANN. Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proceedings of the National Academy of Sciences of the United States of America. WASHINGTON: National Academy of Sciences, 2013, roč. 110, č. 14, s. 5463-5467. ISSN 0027-8424. Dostupné z: https://dx.doi.org/10.1073/pnas.1222379110.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Structure of human enterovirus 71 in complex with a capsid-binding inhibitor
Autoři PLEVKA, Pavel, Rushika PERERA, Moh Lan YAP, Jane CARDOSA, Richard KUHN a Michael G. ROSSMANN.
Vydání Proceedings of the National Academy of Sciences of the United States of America, WASHINGTON, National Academy of Sciences, 2013, 0027-8424.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10600 1.6 Biological sciences
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 9.809
Organizační jednotka Středoevropský technologický institut
Doi http://dx.doi.org/10.1073/pnas.1222379110
UT WoS 000318037800054
Klíčová slova anglicky stability; virus
Štítky neMU
Změnil Změnila: Mgr. Eva Špillingová, učo 110713. Změněno: 29. 3. 2017 12:22.
Anotace
Human enterovirus 71 is a picornavirus causing hand, foot, and mouth disease that may progress to fatal encephalitis in infants and small children. As of now, no cure is available for enterovirus 71 infections. Small molecule inhibitors binding into a hydrophobic pocket within capsid viral protein 1 were previously shown to effectively limit infectivity of many picornaviruses. Here we report a 3.2-angstrom-resolution X-ray structure of the enterovirus 71 virion complexed with the capsid-binding inhibitor WIN 51711. The inhibitor replaced the natural pocket factor within the viral protein 1 pocket without inducing any detectable rearrangements in the structure of the capsid. Furthermore, we show that the compound stabilizes enterovirus 71 virions and limits its infectivity, probably through restricting dynamics of the capsid necessary for genome release. Thus, our results provide a structural basis for development of antienterovirus 71 capsid-binding drugs.
VytisknoutZobrazeno: 22. 7. 2024 00:25